# Value in Health

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/value-in-health/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 3,200 |
| Citations | 221,676 |
| h-index | 169 |
| Homepage | https://www.journals.elsevier.com/value-in-health |
| Open Access | false |
| ISSN-L | 1098-3015 |
| ISSNs | 1098-3015,1524-4733 |
| OpenAlex ID | https://openalex.org/S678965 |
| Publisher | Elsevier BV |
| Works | 79,943 |

## Journal papers

Showing 12 of 179.

- [Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force](https://scholariq.org/papers/consolidated-health-economic-evaluation-reporting-standards-cheers-explanation/)
- [Conjoint Analysis Applications in Health—a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force](https://scholariq.org/papers/conjoint-analysis-applications-in-health-a-checklist-a-report-of-the-ispor-good/)
- [Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force](https://scholariq.org/papers/constructing-experimental-designs-for-discrete-choice-experiments-report-of-the/)
- [Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force](https://scholariq.org/papers/statistical-methods-for-the-analysis-of-discrete-choice-experiments-a-report-of/)
- [An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds](https://scholariq.org/papers/an-economic-evaluation-of-the-impact-cost-and-medicare-policy-implications-of/)
- [Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations](https://scholariq.org/papers/consolidated-health-economic-evaluation-reporting-standards-2022-cheers-2022/)
- [Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1](https://scholariq.org/papers/interpreting-indirect-treatment-comparisons-and-network-meta-analysis-for-health/)
- [Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research](https://scholariq.org/papers/country-level-cost-effectiveness-thresholds-initial-estimates-and-the-need-for/)
- [Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge?](https://scholariq.org/papers/use-of-cost-effectiveness-analysis-in-health-care-resource-allocation-decision/)
- [Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2](https://scholariq.org/papers/conducting-indirect-treatment-comparison-and-network-meta-analysis-studies/)
- [Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report](https://scholariq.org/papers/good-research-practices-for-cost-effectiveness-analysis-alongside-clinical/)
- [Estimating an EQ-5D-5L Value Set for China](https://scholariq.org/papers/estimating-an-eq-5d-5l-value-set-for-china/)

## Journal top topics

Showing 8 of 25.

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)
- [Pharmaceutical studies and practices](https://scholariq.org/topics/pharmaceutical-studies-and-practices/)
- [Healthcare Policy and Management](https://scholariq.org/topics/healthcare-policy-and-management/)
- [Pharmaceutical Practices and Patient Outcomes](https://scholariq.org/topics/pharmaceutical-practices-and-patient-outcomes/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.